A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

NCT02694978 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2014

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency Anemia

Interventions

DRUG: Ferumoxytol
DRUG: FCM

Sponsor

AMAG Pharmaceuticals, Inc.